Eli Lilly raises annual revenue forecast as GLP-1 drugs fuel growth - Reuters
Eli Lilly raises annual revenue forecast as GLP-1 drugs fuel growth Reuters
Coverage by Political Leaning
See how different sides of the spectrum reported this story
Key People
No people linked to this story
Locations
All Coverage
<a href="https://news.google.com/rss/articles/CBMi3wFBVV95cUxNQUM2ak5mV1hSTDU0UzlDQVoxVERuOTNXT1p5OTJmbkdjaWFlVHBnLTVORDZkQmdBY0hFYlZCZzJsaV9lZTl5QXBFMUFLNDBkYmxoRi1CUXZncTVOZnE3NXFzb1dGdG93d2Q3MHpQelNsLV9jbzREblJEMmtOSTZBbTkwaGxzc3ItV0RPNGJHNk04Ti1kaEQ0UG04ekxRNk94SHBuUFprcl9kY2Y3dmxuTjh5RHBaQWdlR1Y4T0hTTjRZY1QwMnhjaXJzQTJNZjl1WlpPUFFmcVBCTkNBc253?oc=5" target="_blank">Eli Lilly raises annual revenue forecast as GLP-1 drugs fuel growth</a> <font color="#6f6f6f">Reuters</font>
Similar Stories
Related coverage based on topic and tags
Venezuela's president expects third-quarter growth after earthquake hit - Reuters
Venezuela's president expects third-quarter growth after earthquake hit Reuters
October 8, 2026 at 08:59 PMArgenx discontinues Vyvgart study in Sjögren's disease, shares tumble - Reuters
Argenx discontinues Vyvgart study in Sjögren's disease, shares tumble Reuters
October 8, 2026 at 08:49 PMNvidia-backed Iambic Therapeutics launches IPO as biotechs buck market gloom - Reuters
Nvidia-backed Iambic Therapeutics launches IPO as biotechs buck market gloom Reuters
October 8, 2026 at 06:18 PMViatris bets on non-opioid pain drugs with $1.65 billion Pacira deal - Reuters
Viatris bets on non-opioid pain drugs with $1.65 billion Pacira deal Reuters
October 8, 2026 at 02:39 PMWorld Bank sees Nigeria growth averaging 4.4% through 2028 - Reuters
World Bank sees Nigeria growth averaging 4.4% through 2028 Reuters
October 8, 2026 at 02:15 PMThe Bottom Line
What's going wrong with the largest economy in Europe?
October 8, 2026 at 11:30 AM